| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding | |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | Entrez:7422 MIM:192240 HGNC:HGNC:12680 Ensembl:ENSG00000112715 AllianceGenome:HGNC:12680 | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | |||||
| Description | vascular endothelial growth factor A | |||||
| GTO ID | GTC1245 |
| Trial ID | NCT00295828 |
| Disease | Diabetic Retinopathy |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Target gene |
| Therapy | Aptamer |
| Treatment | Macugen|pegaptanib|EYE001 |
| Co-treatment | Panretinal Photocoagulation (PRP) |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Pilot Study for the Treatment of Iris Neovascularization With Macugen |
| Year | 2006 |
| Country | United States |
| Company sponsor | Hermann Eye Center |
| Other ID(s) | HEF-0510 |
| Cohort1: Panretinal Photocoagulation (PRP) | |||||||
|
|||||||
| Cohort2: pegaptanib_Panretinal Photocoagulation (PRP) | |||||||
|
|||||||